Andrew D Fesnak, MD

faculty photo
Assistant Professor of Clinical Pathology and Laboratory Medicine
Department: Pathology and Laboratory Medicine

Contact information
3 White Building
Hospital of the University of Pennsylvania
Philadephia, PA 19104
Office: 215-662-3325
BA (Molecular Biology)
Princeton University, 2005.
University of Medicine and Dentistry of New Jersey - Robert Wood Johnson School of Medicine, 2011.
MS (Health Care Innovation)
University of Pennsylvania, 2019.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Fesnak A, Levine B: Good Manufacturing Practices Facilities for Cellular Therapy. Immunotherapy in Translational Cancer Research. Cooper LJN, Mittendorf EA, Moyes J, Prabhakaran S (eds.). John Wiley & Sons Inc. Page: 177, Feb 2018.

Fesnak AD, Hanley PJ, Levine BL: Considerations in T Cell Therapy Product Development for B cell leukemia and lymphoma immunotherapy. Curr Hematol Malig Rep Jul 2017.

Levine B, Fesnak A, Riviere I: Showcasing Clinical Development and Production of Cellular Therapies. Mol Ther 25(4): 827-828, April 2017.

Fesnak A, Suhoski Davis M, Levine B: Production of chimeric antigen receptor (CAR) T cells. Nature Protocols. Clyne M, Barnes K (eds.). Springer Nature, 12(4), April 2017.

Fesnak A, O'Doherty U: Clinical Development and Manufacture of Chimeric Antigen Receptor T cells and the Role of Leukapheresis. European Oncology and Hematology 13(1), 2017.

Davis, M. M., Fesnak, A., Leskowitz, R. M., McKee, J. S., Ohayon, Y., Corl, C. M., Malykhin, A., Fraietta, J. A., Melenhorst, J. J., June, C., Schuster, S., Levine, B. L.: Predictors of Manufacturing (Mfg) Success for Chimeric Antigen Receptor (Car) T Cells in Non-Hodgkin Lymphoma. Cytotherapy 19(5): S79-S80, 2017.

Fesnak, A., Lin, C. Y., Siegel, D. L., Maus, M. V.: CAR-T Cell Therapies From the Transfusion Medicine Perspective. Transfusion Medicine Reviews 30(3): 139-145, 2016.

Levine, B. L., Maude, S., Zheng, Z., Shaw, P., Ambrose, D., Aplenc, R., Barker, C., Barrett, D., Brogdon, J., Callahan, C., Chen, F., Chew, A., Davis, M. M. S., Fesnak, A. D., Finklestein, J., Frey, N., Lacey, S., Lamontagne, A., Lewitt, L., Loew, A., Marcucci, K., Melenhorst, J., Motley, L., Mudambi, M., Nazimuddin, F., O'Rourke, M., Porter, D., Rheingold, S. R., Scholler, J., Tayor, C., White, C., Wood, P., Young, R., Teachey, D. T., June, C., Grupp, S.: Durable Remissions with Control of Cytokine Release Syndrome (Crs) Using T Cells Expressing Cd19 Targeted Chimeric Antigen Receptor (Car) Ctl019 to Treat Relapsed/Refractory (R/R) Acute Lymphoid Leukemia (All). Cytotherapy 18(6): S14-S15, 2016.

Fesnak A, Levine B: Immunotherapy with Autologous Cells. Reviews in Cell Biology and Molecular Medicine. Wiley-VCH Verlag GmbH & Co. KGaA, 2016.

Fesnak, A. D., June, C. H., Levine, B. L.: Engineered T cells: the promise and challenges of cancer immunotherapy. Nature Reviews Cancer 16(9): 566-581, 2016.

back to top
Last updated: 03/13/2018
The Trustees of the University of Pennsylvania